Sleep Disorders Trial, Recruiting NCT07446595 Sponsor: University of Colorado, Denver Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07446595
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People with a body mass index (a measure of body weight relative to height) between 25 and 45
  • People who have been diagnosed with any type of adult cancer within the past 10 years
  • People who have finished active cancer treatment (such as surgery, radiation, or chemotherapy) with the goal of curing the cancer, at least 3 months ago but no more than 10 years ago — or people currently on active surveillance with no treatment; ongoing targeted or hormone therapies for at least 3 months, or maintenance therapy for at least 1 year, may also be acceptable (confirm with trial site for individual circumstances)
  • People who already have a regular doctor (or are willing to find one before joining the study) who can address any health issues that come up and give approval to take part in a nutrition and exercise program
  • People who are able and willing to take part in a supervised exercise program, as assessed by standard readiness questionnaires
  • People who speak English
  • People who have access to a computer or smartphone and internet to join video meetings, complete surveys, and access virtual exercise sessions
  • People who live or work within 30 miles of the study centre (exceptions may be considered by the study lead on a case-by-case basis)
  • People who are not planning major elective surgery, travel of more than 2 consecutive weeks, or moving home during the approximately 6-month program
  • People who have not used nicotine or tobacco products in the past 6 months
  • People who are willing to avoid all nutritional supplements not prescribed by a doctor for the duration of the study
  • People who are willing and able to give informed consent and understand the study rules
  • People who are willing to attend weekly group education sessions, monthly skills sessions, weekly group support sessions, and monthly one-on-one sessions with a registered dietitian
  • People who are willing to attend up to two exercise sessions per week for the first 12 weeks (one in-person, one virtual), then one supervised session per month and one virtual session per week for the following 12 weeks
  • People whose current diet or physical activity levels do not yet meet recommended healthy guidelines, as measured by standard questionnaires (exceptions may be considered by the study lead on a case-by-case basis)

Who may not be able to join:

  • People with a significant decline in their ability to carry out daily activities due to their health condition, as measured by a standard cancer performance scale (confirm with trial site)
  • People who are currently receiving chemotherapy, radiation, or immunotherapy aimed at curing their cancer, or who finished surgery, chemotherapy, or radiation less than 3 months ago, or who recently started targeted or hormonal therapy (unless well-tolerated and approved by the study lead)
  • People who completed active or maintenance cancer treatment more than 10 years ago
  • People who plan to move home within the next 6 months
  • People who plan to travel for more than 2 consecutive weeks within the next 6 months
  • Women who are currently pregnant or breastfeeding, were pregnant in the past 6 months, or are planning to become pregnant in the next 18 months; women of childbearing potential who are sexually active may be considered if they have had a tubal ligation or use a reliable form of contraception
  • People who have had major surgery within the past 3 months or have planned elective surgery during the study period, including breast removal surgery
  • People who have had treatment that significantly affects digestion or how the body processes food (for example, surgical removal of the oesophagus, stomach, or colon)
  • People who have had a serious heart event (such as a heart attack, unstable chest pain, a procedure to open blocked heart arteries, stroke, or blood clot in the lungs) in the past 6 months
  • People who have symptoms that may suggest heart or circulation problems, such as chest pain, shortness of breath at rest or with light activity, dizziness, or fainting
  • People with uncontrolled high blood pressure or a resting heart rate above 100 beats per minute, as measured at the screening visit
  • People with diabetes that is not well controlled, or whose blood sugar levels are above a certain threshold on testing — unless the diabetes is well managed with specific medications and blood sugar is within an acceptable range (confirm with trial site)
  • People with an uncontrolled thyroid condition (a treated and stable thyroid condition is acceptable)
  • People with very high triglyceride (a type of fat in the blood) levels above 500 mg/dL, as measured at screening
  • People with very high LDL cholesterol (sometimes called "bad" cholesterol) levels above 200 mg/dL, as measured at screening
  • People with other significant ongoing health conditions that could make it unsafe to take part in a diet and exercise program, such as serious heart rhythm problems, heart valve disease, significant digestive, lung, kidney, muscle or joint, neurological, blood, or psychiatric conditions
  • People who have started new cholesterol-lowering, blood pressure, or blood sugar medications within the past 3 months
  • People who are regularly taking prescription or over-the-counter medications known to significantly affect appetite, weight, or energy — such as weight loss drugs, appetite suppressants, lithium, stimulants, antipsychotics, or certain antidepressants (some exceptions apply — confirm with trial site)
  • People who are currently using, or have used in the past 6 months, steroid medications taken throughout the body (such as prednisone), unless taken as a low-dose replacement for a specific hormonal condition
  • People who have previously had weight loss surgery or a weight loss device implanted, with certain exceptions if the procedure or device removal was more than 1 year before screening (confirm with trial site for specific situations)
  • People who have participated in a formal nutrition, weight loss, or physical activity program or clinical trial in the past 6 months, are currently participating in one, or plan to do so in the next 6 months
  • People who have previously taken part in the BfitBwell exercise oncology program within the past 3 years (exceptions may be considered by the study lead)
  • People who currently use or have used nicotine or tobacco products in the past 6 months
  • People with current alcohol or substance misuse concerns, as assessed by a standard screening questionnaire
  • People with a history of a clinically diagnosed eating disorder, or whose responses to eating-related questionnaires suggest a possible eating disorder — further assessment by the study doctor would be needed to determine suitability
  • People with current severe depression or a history of severe depression within the past year that, in the opinion of the study doctor, would interfere with their ability to follow the program
  • People with a history of other significant psychiatric conditions (such as psychosis, schizophrenia, or bipolar disorder) that, in the opinion of the study doctor, would interfere with their ability to follow the program
  • People with physical limitations or medical reasons that prevent safe participation in physical activity, or who are considered high-risk based on standard exercise safety guidelines
  • People who are not able to give informed consent due to cognitive difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emily Hill, PhD, RDN, University of Colorado, Denver

Phone: 303-724-2488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Determine the research protocol recruitment feasibility of the augmented BfedBwell nutrition intervention; Determine the research protocol adherence feasibility of the augmented BfedBwell nutrition intervention; Determine the research protocol outcome assessment feasibility of the augmented BfedBwell nutrition intervention; Determine the research protocol retention feasibility of the augmented BfedBwell nutrition intervention; Determine the intervention acceptability by participants during focus groups; Determine the intervention acceptability by participants using the Net Promoter Score (NPS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov